Global CAR-NK Cell Therapy Market Growth (Status and Outlook) 2026-2032
The global CAR-NK Cell Therapy market size is predicted to grow from US$ 2317 million in 2025 to US$ 3439 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.
CAR-NK cell therapy is an advanced cellular therapy technique that combines the natural anticancer ability of natural killer (NK) cells with the specific targeting function of chimeric antigen receptors (CARs). Through genetic engineering, CAR structures capable of recognizing specific tumor antigens are introduced into NK cells, thereby enhancing their targeting ability and killing power. This therapy has shown great potential in treating various types of cancers, including hematological tumors and solid tumors. CAR-NK cell therapy has lower toxic and side effects and better safety, making it a promising supplement or alternative to CAR-T cell therapy.
Market Drivers
Superior Safety and "Off-the-Shelf" Potential over CAR-T therapies is a critical driver. CAR-NK cells carry a significantly lower risk of cytokine release syndrome (CRS), neurotoxicity, and graft-versus-host disease (GvHD). Furthermore, they can be developed as allogeneic, "off-the-shelf" products from healthy donors, unlike patient-specific CAR-T cells. This enables faster, more scalable, and cost-effective production.
Technological Advancements and Clinical Progress are accelerating market growth. These include the development of genetically engineered CAR-NK cells, integration of induced pluripotent stem cell (iPSC)-derived NK cells for mass production, and improved cryopreservation techniques. The pipeline is robust, with numerous companies advancing therapies into late-stage clinical trials.
LPI (LP Information)' newest research report, the “CAR-NK Cell Therapy Industry Forecast” looks at past sales and reviews total world CAR-NK Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-NK Cell Therapy sales for 2026 through 2032. With CAR-NK Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-NK Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global CAR-NK Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-NK Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-NK Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-NK Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-NK Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-NK Cell Therapy market by product type, application, key players and key regions and countries.
CAR-NK cell therapy is an advanced cellular therapy technique that combines the natural anticancer ability of natural killer (NK) cells with the specific targeting function of chimeric antigen receptors (CARs). Through genetic engineering, CAR structures capable of recognizing specific tumor antigens are introduced into NK cells, thereby enhancing their targeting ability and killing power. This therapy has shown great potential in treating various types of cancers, including hematological tumors and solid tumors. CAR-NK cell therapy has lower toxic and side effects and better safety, making it a promising supplement or alternative to CAR-T cell therapy.
Market Drivers
Superior Safety and "Off-the-Shelf" Potential over CAR-T therapies is a critical driver. CAR-NK cells carry a significantly lower risk of cytokine release syndrome (CRS), neurotoxicity, and graft-versus-host disease (GvHD). Furthermore, they can be developed as allogeneic, "off-the-shelf" products from healthy donors, unlike patient-specific CAR-T cells. This enables faster, more scalable, and cost-effective production.
Technological Advancements and Clinical Progress are accelerating market growth. These include the development of genetically engineered CAR-NK cells, integration of induced pluripotent stem cell (iPSC)-derived NK cells for mass production, and improved cryopreservation techniques. The pipeline is robust, with numerous companies advancing therapies into late-stage clinical trials.
LPI (LP Information)' newest research report, the “CAR-NK Cell Therapy Industry Forecast” looks at past sales and reviews total world CAR-NK Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-NK Cell Therapy sales for 2026 through 2032. With CAR-NK Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-NK Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global CAR-NK Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-NK Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-NK Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-NK Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-NK Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-NK Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cytokine Therapy
- Adoptive NK Cell Therapy
- Genetically Engineered NK Cell Therapy
- Others
Segmentation by Cell Source:
- Peripheral Blood (PB)
- Umbilical Cord Blood (CB)
- Induced Pluripotent Stem Cells (iPSCs)
- NK Cell Lines (e.g., NK-92)
Segmentation by Product Generation:
- First Generation
- Second/Third Generation
- Fourth Generation
Segmentation by Application:
- Solid Tumors
- Hematological Malignancies
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Artiva Biotherapeutics
- Cartherics
- Cytoimmune Therapeutics
- Dragonfly Therapeutics
- Fate Therapeutics
- Glycostem Therapeutics
- ImmuneBridge
- ImmunityBio
- Nkarta
- NKGen Biotech
- ONK Therapeutics
- Senti Biosciences
- Base Therapeutics
- Persongen
- Alpha Biopharma
- Guangzhou Doublle Bioproduct
- Rui Therapeutics
- Allife Medicine
- Morecell
- Simnova
- Nuwacell
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-NK Cell Therapy Market Size (2021-2032)
2.1.2 CAR-NK Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-NK Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 CAR-NK Cell Therapy Segment by Type
2.2.1 Cytokine Therapy
2.2.2 Adoptive NK Cell Therapy
2.2.3 Genetically Engineered NK Cell Therapy
2.2.4 Others
2.2.5 CAR-NK Cell Therapy Market Size by Type
2.2.5.1 CAR-NK Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 CAR-NK Cell Therapy Segment by Cell Source
2.3.1 Peripheral Blood (PB)
2.3.2 Umbilical Cord Blood (CB)
2.3.3 Induced Pluripotent Stem Cells (iPSCs)
2.3.4 NK Cell Lines (e.g., NK-92)
2.3.5 CAR-NK Cell Therapy Market Size by Cell Source
2.3.5.1 CAR-NK Cell Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032)
2.3.5.2 Global CAR-NK Cell Therapy Market Size Market Share by Cell Source (2021-2026)
2.4 CAR-NK Cell Therapy Segment by Product Generation
2.4.1 First Generation
2.4.2 Second/Third Generation
2.4.3 Fourth Generation
2.4.4 CAR-NK Cell Therapy Market Size by Product Generation
2.4.4.1 CAR-NK Cell Therapy Market Size CAGR by Product Generation (2021 VS 2025 VS 2032)
2.4.4.2 Global CAR-NK Cell Therapy Market Size Market Share by Product Generation (2021-2026)
2.5 CAR-NK Cell Therapy Segment by Application
2.5.1 Solid Tumors
2.5.2 Hematological Malignancies
2.5.3 CAR-NK Cell Therapy Market Size by Application
2.5.3.1 CAR-NK Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
3 CAR-NK CELL THERAPY MARKET SIZE BY PLAYER
3.1 CAR-NK Cell Therapy Market Size Market Share by Player
3.1.1 Global CAR-NK Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global CAR-NK Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global CAR-NK Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-NK CELL THERAPY BY REGION
4.1 CAR-NK Cell Therapy Market Size by Region (2021-2026)
4.2 Global CAR-NK Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-NK Cell Therapy Market Size Growth (2021-2026)
4.4 APAC CAR-NK Cell Therapy Market Size Growth (2021-2026)
4.5 Europe CAR-NK Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-NK Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-NK Cell Therapy Market Size by Country (2021-2026)
5.2 Americas CAR-NK Cell Therapy Market Size by Type (2021-2026)
5.3 Americas CAR-NK Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-NK Cell Therapy Market Size by Region (2021-2026)
6.2 APAC CAR-NK Cell Therapy Market Size by Type (2021-2026)
6.3 APAC CAR-NK Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-NK Cell Therapy Market Size by Country (2021-2026)
7.2 Europe CAR-NK Cell Therapy Market Size by Type (2021-2026)
7.3 Europe CAR-NK Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-NK Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa CAR-NK Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR-NK Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-NK CELL THERAPY MARKET FORECAST
10.1 Global CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas CAR-NK Cell Therapy Forecast
10.1.3 APAC CAR-NK Cell Therapy Forecast
10.1.4 Europe CAR-NK Cell Therapy Forecast
10.1.5 Middle East & Africa CAR-NK Cell Therapy Forecast
10.2 Americas CAR-NK Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market CAR-NK Cell Therapy Forecast
10.2.2 Canada Market CAR-NK Cell Therapy Forecast
10.2.3 Mexico Market CAR-NK Cell Therapy Forecast
10.2.4 Brazil Market CAR-NK Cell Therapy Forecast
10.3 APAC CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.3.1 China CAR-NK Cell Therapy Market Forecast
10.3.2 Japan Market CAR-NK Cell Therapy Forecast
10.3.3 Korea Market CAR-NK Cell Therapy Forecast
10.3.4 Southeast Asia Market CAR-NK Cell Therapy Forecast
10.3.5 India Market CAR-NK Cell Therapy Forecast
10.3.6 Australia Market CAR-NK Cell Therapy Forecast
10.4 Europe CAR-NK Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-NK Cell Therapy Forecast
10.4.2 France Market CAR-NK Cell Therapy Forecast
10.4.3 UK Market CAR-NK Cell Therapy Forecast
10.4.4 Italy Market CAR-NK Cell Therapy Forecast
10.4.5 Russia Market CAR-NK Cell Therapy Forecast
10.5 Middle East & Africa CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-NK Cell Therapy Forecast
10.5.2 South Africa Market CAR-NK Cell Therapy Forecast
10.5.3 Israel Market CAR-NK Cell Therapy Forecast
10.5.4 Turkey Market CAR-NK Cell Therapy Forecast
10.6 Global CAR-NK Cell Therapy Forecast by Type (2027-2032)
10.7 Global CAR-NK Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-NK Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Artiva Biotherapeutics
11.1.1 Artiva Biotherapeutics Company Information
11.1.2 Artiva Biotherapeutics CAR-NK Cell Therapy Product Offered
11.1.3 Artiva Biotherapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Artiva Biotherapeutics Main Business Overview
11.1.5 Artiva Biotherapeutics Latest Developments
11.2 Cartherics
11.2.1 Cartherics Company Information
11.2.2 Cartherics CAR-NK Cell Therapy Product Offered
11.2.3 Cartherics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Cartherics Main Business Overview
11.2.5 Cartherics Latest Developments
11.3 Cytoimmune Therapeutics
11.3.1 Cytoimmune Therapeutics Company Information
11.3.2 Cytoimmune Therapeutics CAR-NK Cell Therapy Product Offered
11.3.3 Cytoimmune Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Cytoimmune Therapeutics Main Business Overview
11.3.5 Cytoimmune Therapeutics Latest Developments
11.4 Dragonfly Therapeutics
11.4.1 Dragonfly Therapeutics Company Information
11.4.2 Dragonfly Therapeutics CAR-NK Cell Therapy Product Offered
11.4.3 Dragonfly Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Dragonfly Therapeutics Main Business Overview
11.4.5 Dragonfly Therapeutics Latest Developments
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Information
11.5.2 Fate Therapeutics CAR-NK Cell Therapy Product Offered
11.5.3 Fate Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fate Therapeutics Main Business Overview
11.5.5 Fate Therapeutics Latest Developments
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Information
11.6.2 Glycostem Therapeutics CAR-NK Cell Therapy Product Offered
11.6.3 Glycostem Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Glycostem Therapeutics Main Business Overview
11.6.5 Glycostem Therapeutics Latest Developments
11.7 ImmuneBridge
11.7.1 ImmuneBridge Company Information
11.7.2 ImmuneBridge CAR-NK Cell Therapy Product Offered
11.7.3 ImmuneBridge CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ImmuneBridge Main Business Overview
11.7.5 ImmuneBridge Latest Developments
11.8 ImmunityBio
11.8.1 ImmunityBio Company Information
11.8.2 ImmunityBio CAR-NK Cell Therapy Product Offered
11.8.3 ImmunityBio CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ImmunityBio Main Business Overview
11.8.5 ImmunityBio Latest Developments
11.9 Nkarta
11.9.1 Nkarta Company Information
11.9.2 Nkarta CAR-NK Cell Therapy Product Offered
11.9.3 Nkarta CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Nkarta Main Business Overview
11.9.5 Nkarta Latest Developments
11.10 NKGen Biotech
11.10.1 NKGen Biotech Company Information
11.10.2 NKGen Biotech CAR-NK Cell Therapy Product Offered
11.10.3 NKGen Biotech CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 NKGen Biotech Main Business Overview
11.10.5 NKGen Biotech Latest Developments
11.11 ONK Therapeutics
11.11.1 ONK Therapeutics Company Information
11.11.2 ONK Therapeutics CAR-NK Cell Therapy Product Offered
11.11.3 ONK Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ONK Therapeutics Main Business Overview
11.11.5 ONK Therapeutics Latest Developments
11.12 Senti Biosciences
11.12.1 Senti Biosciences Company Information
11.12.2 Senti Biosciences CAR-NK Cell Therapy Product Offered
11.12.3 Senti Biosciences CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Senti Biosciences Main Business Overview
11.12.5 Senti Biosciences Latest Developments
11.13 Base Therapeutics
11.13.1 Base Therapeutics Company Information
11.13.2 Base Therapeutics CAR-NK Cell Therapy Product Offered
11.13.3 Base Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Base Therapeutics Main Business Overview
11.13.5 Base Therapeutics Latest Developments
11.14 Persongen
11.14.1 Persongen Company Information
11.14.2 Persongen CAR-NK Cell Therapy Product Offered
11.14.3 Persongen CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Persongen Main Business Overview
11.14.5 Persongen Latest Developments
11.15 Alpha Biopharma
11.15.1 Alpha Biopharma Company Information
11.15.2 Alpha Biopharma CAR-NK Cell Therapy Product Offered
11.15.3 Alpha Biopharma CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Alpha Biopharma Main Business Overview
11.15.5 Alpha Biopharma Latest Developments
11.16 Guangzhou Doublle Bioproduct
11.16.1 Guangzhou Doublle Bioproduct Company Information
11.16.2 Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Product Offered
11.16.3 Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Guangzhou Doublle Bioproduct Main Business Overview
11.16.5 Guangzhou Doublle Bioproduct Latest Developments
11.17 Rui Therapeutics
11.17.1 Rui Therapeutics Company Information
11.17.2 Rui Therapeutics CAR-NK Cell Therapy Product Offered
11.17.3 Rui Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Rui Therapeutics Main Business Overview
11.17.5 Rui Therapeutics Latest Developments
11.18 Allife Medicine
11.18.1 Allife Medicine Company Information
11.18.2 Allife Medicine CAR-NK Cell Therapy Product Offered
11.18.3 Allife Medicine CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Allife Medicine Main Business Overview
11.18.5 Allife Medicine Latest Developments
11.19 Morecell
11.19.1 Morecell Company Information
11.19.2 Morecell CAR-NK Cell Therapy Product Offered
11.19.3 Morecell CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Morecell Main Business Overview
11.19.5 Morecell Latest Developments
11.20 Simnova
11.20.1 Simnova Company Information
11.20.2 Simnova CAR-NK Cell Therapy Product Offered
11.20.3 Simnova CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Simnova Main Business Overview
11.20.5 Simnova Latest Developments
11.21 Nuwacell
11.21.1 Nuwacell Company Information
11.21.2 Nuwacell CAR-NK Cell Therapy Product Offered
11.21.3 Nuwacell CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Nuwacell Main Business Overview
11.21.5 Nuwacell Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-NK Cell Therapy Market Size (2021-2032)
2.1.2 CAR-NK Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-NK Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 CAR-NK Cell Therapy Segment by Type
2.2.1 Cytokine Therapy
2.2.2 Adoptive NK Cell Therapy
2.2.3 Genetically Engineered NK Cell Therapy
2.2.4 Others
2.2.5 CAR-NK Cell Therapy Market Size by Type
2.2.5.1 CAR-NK Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 CAR-NK Cell Therapy Segment by Cell Source
2.3.1 Peripheral Blood (PB)
2.3.2 Umbilical Cord Blood (CB)
2.3.3 Induced Pluripotent Stem Cells (iPSCs)
2.3.4 NK Cell Lines (e.g., NK-92)
2.3.5 CAR-NK Cell Therapy Market Size by Cell Source
2.3.5.1 CAR-NK Cell Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032)
2.3.5.2 Global CAR-NK Cell Therapy Market Size Market Share by Cell Source (2021-2026)
2.4 CAR-NK Cell Therapy Segment by Product Generation
2.4.1 First Generation
2.4.2 Second/Third Generation
2.4.3 Fourth Generation
2.4.4 CAR-NK Cell Therapy Market Size by Product Generation
2.4.4.1 CAR-NK Cell Therapy Market Size CAGR by Product Generation (2021 VS 2025 VS 2032)
2.4.4.2 Global CAR-NK Cell Therapy Market Size Market Share by Product Generation (2021-2026)
2.5 CAR-NK Cell Therapy Segment by Application
2.5.1 Solid Tumors
2.5.2 Hematological Malignancies
2.5.3 CAR-NK Cell Therapy Market Size by Application
2.5.3.1 CAR-NK Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
3 CAR-NK CELL THERAPY MARKET SIZE BY PLAYER
3.1 CAR-NK Cell Therapy Market Size Market Share by Player
3.1.1 Global CAR-NK Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global CAR-NK Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global CAR-NK Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-NK CELL THERAPY BY REGION
4.1 CAR-NK Cell Therapy Market Size by Region (2021-2026)
4.2 Global CAR-NK Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-NK Cell Therapy Market Size Growth (2021-2026)
4.4 APAC CAR-NK Cell Therapy Market Size Growth (2021-2026)
4.5 Europe CAR-NK Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-NK Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-NK Cell Therapy Market Size by Country (2021-2026)
5.2 Americas CAR-NK Cell Therapy Market Size by Type (2021-2026)
5.3 Americas CAR-NK Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-NK Cell Therapy Market Size by Region (2021-2026)
6.2 APAC CAR-NK Cell Therapy Market Size by Type (2021-2026)
6.3 APAC CAR-NK Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-NK Cell Therapy Market Size by Country (2021-2026)
7.2 Europe CAR-NK Cell Therapy Market Size by Type (2021-2026)
7.3 Europe CAR-NK Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-NK Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa CAR-NK Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR-NK Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-NK CELL THERAPY MARKET FORECAST
10.1 Global CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas CAR-NK Cell Therapy Forecast
10.1.3 APAC CAR-NK Cell Therapy Forecast
10.1.4 Europe CAR-NK Cell Therapy Forecast
10.1.5 Middle East & Africa CAR-NK Cell Therapy Forecast
10.2 Americas CAR-NK Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market CAR-NK Cell Therapy Forecast
10.2.2 Canada Market CAR-NK Cell Therapy Forecast
10.2.3 Mexico Market CAR-NK Cell Therapy Forecast
10.2.4 Brazil Market CAR-NK Cell Therapy Forecast
10.3 APAC CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.3.1 China CAR-NK Cell Therapy Market Forecast
10.3.2 Japan Market CAR-NK Cell Therapy Forecast
10.3.3 Korea Market CAR-NK Cell Therapy Forecast
10.3.4 Southeast Asia Market CAR-NK Cell Therapy Forecast
10.3.5 India Market CAR-NK Cell Therapy Forecast
10.3.6 Australia Market CAR-NK Cell Therapy Forecast
10.4 Europe CAR-NK Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-NK Cell Therapy Forecast
10.4.2 France Market CAR-NK Cell Therapy Forecast
10.4.3 UK Market CAR-NK Cell Therapy Forecast
10.4.4 Italy Market CAR-NK Cell Therapy Forecast
10.4.5 Russia Market CAR-NK Cell Therapy Forecast
10.5 Middle East & Africa CAR-NK Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-NK Cell Therapy Forecast
10.5.2 South Africa Market CAR-NK Cell Therapy Forecast
10.5.3 Israel Market CAR-NK Cell Therapy Forecast
10.5.4 Turkey Market CAR-NK Cell Therapy Forecast
10.6 Global CAR-NK Cell Therapy Forecast by Type (2027-2032)
10.7 Global CAR-NK Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-NK Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Artiva Biotherapeutics
11.1.1 Artiva Biotherapeutics Company Information
11.1.2 Artiva Biotherapeutics CAR-NK Cell Therapy Product Offered
11.1.3 Artiva Biotherapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Artiva Biotherapeutics Main Business Overview
11.1.5 Artiva Biotherapeutics Latest Developments
11.2 Cartherics
11.2.1 Cartherics Company Information
11.2.2 Cartherics CAR-NK Cell Therapy Product Offered
11.2.3 Cartherics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Cartherics Main Business Overview
11.2.5 Cartherics Latest Developments
11.3 Cytoimmune Therapeutics
11.3.1 Cytoimmune Therapeutics Company Information
11.3.2 Cytoimmune Therapeutics CAR-NK Cell Therapy Product Offered
11.3.3 Cytoimmune Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Cytoimmune Therapeutics Main Business Overview
11.3.5 Cytoimmune Therapeutics Latest Developments
11.4 Dragonfly Therapeutics
11.4.1 Dragonfly Therapeutics Company Information
11.4.2 Dragonfly Therapeutics CAR-NK Cell Therapy Product Offered
11.4.3 Dragonfly Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Dragonfly Therapeutics Main Business Overview
11.4.5 Dragonfly Therapeutics Latest Developments
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Information
11.5.2 Fate Therapeutics CAR-NK Cell Therapy Product Offered
11.5.3 Fate Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fate Therapeutics Main Business Overview
11.5.5 Fate Therapeutics Latest Developments
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Information
11.6.2 Glycostem Therapeutics CAR-NK Cell Therapy Product Offered
11.6.3 Glycostem Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Glycostem Therapeutics Main Business Overview
11.6.5 Glycostem Therapeutics Latest Developments
11.7 ImmuneBridge
11.7.1 ImmuneBridge Company Information
11.7.2 ImmuneBridge CAR-NK Cell Therapy Product Offered
11.7.3 ImmuneBridge CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ImmuneBridge Main Business Overview
11.7.5 ImmuneBridge Latest Developments
11.8 ImmunityBio
11.8.1 ImmunityBio Company Information
11.8.2 ImmunityBio CAR-NK Cell Therapy Product Offered
11.8.3 ImmunityBio CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ImmunityBio Main Business Overview
11.8.5 ImmunityBio Latest Developments
11.9 Nkarta
11.9.1 Nkarta Company Information
11.9.2 Nkarta CAR-NK Cell Therapy Product Offered
11.9.3 Nkarta CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Nkarta Main Business Overview
11.9.5 Nkarta Latest Developments
11.10 NKGen Biotech
11.10.1 NKGen Biotech Company Information
11.10.2 NKGen Biotech CAR-NK Cell Therapy Product Offered
11.10.3 NKGen Biotech CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 NKGen Biotech Main Business Overview
11.10.5 NKGen Biotech Latest Developments
11.11 ONK Therapeutics
11.11.1 ONK Therapeutics Company Information
11.11.2 ONK Therapeutics CAR-NK Cell Therapy Product Offered
11.11.3 ONK Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ONK Therapeutics Main Business Overview
11.11.5 ONK Therapeutics Latest Developments
11.12 Senti Biosciences
11.12.1 Senti Biosciences Company Information
11.12.2 Senti Biosciences CAR-NK Cell Therapy Product Offered
11.12.3 Senti Biosciences CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Senti Biosciences Main Business Overview
11.12.5 Senti Biosciences Latest Developments
11.13 Base Therapeutics
11.13.1 Base Therapeutics Company Information
11.13.2 Base Therapeutics CAR-NK Cell Therapy Product Offered
11.13.3 Base Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Base Therapeutics Main Business Overview
11.13.5 Base Therapeutics Latest Developments
11.14 Persongen
11.14.1 Persongen Company Information
11.14.2 Persongen CAR-NK Cell Therapy Product Offered
11.14.3 Persongen CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Persongen Main Business Overview
11.14.5 Persongen Latest Developments
11.15 Alpha Biopharma
11.15.1 Alpha Biopharma Company Information
11.15.2 Alpha Biopharma CAR-NK Cell Therapy Product Offered
11.15.3 Alpha Biopharma CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Alpha Biopharma Main Business Overview
11.15.5 Alpha Biopharma Latest Developments
11.16 Guangzhou Doublle Bioproduct
11.16.1 Guangzhou Doublle Bioproduct Company Information
11.16.2 Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Product Offered
11.16.3 Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Guangzhou Doublle Bioproduct Main Business Overview
11.16.5 Guangzhou Doublle Bioproduct Latest Developments
11.17 Rui Therapeutics
11.17.1 Rui Therapeutics Company Information
11.17.2 Rui Therapeutics CAR-NK Cell Therapy Product Offered
11.17.3 Rui Therapeutics CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Rui Therapeutics Main Business Overview
11.17.5 Rui Therapeutics Latest Developments
11.18 Allife Medicine
11.18.1 Allife Medicine Company Information
11.18.2 Allife Medicine CAR-NK Cell Therapy Product Offered
11.18.3 Allife Medicine CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Allife Medicine Main Business Overview
11.18.5 Allife Medicine Latest Developments
11.19 Morecell
11.19.1 Morecell Company Information
11.19.2 Morecell CAR-NK Cell Therapy Product Offered
11.19.3 Morecell CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Morecell Main Business Overview
11.19.5 Morecell Latest Developments
11.20 Simnova
11.20.1 Simnova Company Information
11.20.2 Simnova CAR-NK Cell Therapy Product Offered
11.20.3 Simnova CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Simnova Main Business Overview
11.20.5 Simnova Latest Developments
11.21 Nuwacell
11.21.1 Nuwacell Company Information
11.21.2 Nuwacell CAR-NK Cell Therapy Product Offered
11.21.3 Nuwacell CAR-NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Nuwacell Main Business Overview
11.21.5 Nuwacell Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR-NK Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-NK Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cytokine Therapy
Table 4. Major Players of Adoptive NK Cell Therapy
Table 5. Major Players of Genetically Engineered NK Cell Therapy
Table 6. Major Players of Others
Table 7. CAR-NK Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 9. Global CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Peripheral Blood (PB)
Table 11. Major Players of Umbilical Cord Blood (CB)
Table 12. Major Players of Induced Pluripotent Stem Cells (iPSCs)
Table 13. Major Players of NK Cell Lines (e.g., NK-92)
Table 14. CAR-NK Cell Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global CAR-NK Cell Therapy Market Size by Cell Source (2021-2026) & ($ millions)
Table 16. Global CAR-NK Cell Therapy Market Size Market Share by Cell Source (2021-2026)
Table 17. Major Players of First Generation
Table 18. Major Players of Second/Third Generation
Table 19. Major Players of Fourth Generation
Table 20. CAR-NK Cell Therapy Market Size CAGR by Product Generation (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global CAR-NK Cell Therapy Market Size by Product Generation (2021-2026) & ($ millions)
Table 22. Global CAR-NK Cell Therapy Market Size Market Share by Product Generation (2021-2026)
Table 23. CAR-NK Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 25. Global CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Table 26. Global CAR-NK Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 27. Global CAR-NK Cell Therapy Revenue Market Share by Player (2021-2026)
Table 28. CAR-NK Cell Therapy Key Players Head office and Products Offered
Table 29. CAR-NK Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global CAR-NK Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 33. Global CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Table 34. Global CAR-NK Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global CAR-NK Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas CAR-NK Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas CAR-NK Cell Therapy Market Size Market Share by Country (2021-2026)
Table 38. Americas CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Table 40. Americas CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Table 42. APAC CAR-NK Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Table 44. APAC CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe CAR-NK Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe CAR-NK Cell Therapy Market Size Market Share by Country (2021-2026)
Table 48. Europe CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa CAR-NK Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of CAR-NK Cell Therapy
Table 54. Key Market Challenges & Risks of CAR-NK Cell Therapy
Table 55. Key Industry Trends of CAR-NK Cell Therapy
Table 56. Global CAR-NK Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global CAR-NK Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global CAR-NK Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global CAR-NK Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. Artiva Biotherapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 61. Artiva Biotherapeutics CAR-NK Cell Therapy Product Offered
Table 62. Artiva Biotherapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Artiva Biotherapeutics Main Business
Table 64. Artiva Biotherapeutics Latest Developments
Table 65. Cartherics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 66. Cartherics CAR-NK Cell Therapy Product Offered
Table 67. Cartherics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Cartherics Main Business
Table 69. Cartherics Latest Developments
Table 70. Cytoimmune Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 71. Cytoimmune Therapeutics CAR-NK Cell Therapy Product Offered
Table 72. Cytoimmune Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Cytoimmune Therapeutics Main Business
Table 74. Cytoimmune Therapeutics Latest Developments
Table 75. Dragonfly Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 76. Dragonfly Therapeutics CAR-NK Cell Therapy Product Offered
Table 77. Dragonfly Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Dragonfly Therapeutics Main Business
Table 79. Dragonfly Therapeutics Latest Developments
Table 80. Fate Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 81. Fate Therapeutics CAR-NK Cell Therapy Product Offered
Table 82. Fate Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Fate Therapeutics Main Business
Table 84. Fate Therapeutics Latest Developments
Table 85. Glycostem Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 86. Glycostem Therapeutics CAR-NK Cell Therapy Product Offered
Table 87. Glycostem Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Glycostem Therapeutics Main Business
Table 89. Glycostem Therapeutics Latest Developments
Table 90. ImmuneBridge Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 91. ImmuneBridge CAR-NK Cell Therapy Product Offered
Table 92. ImmuneBridge CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. ImmuneBridge Main Business
Table 94. ImmuneBridge Latest Developments
Table 95. ImmunityBio Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 96. ImmunityBio CAR-NK Cell Therapy Product Offered
Table 97. ImmunityBio CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. ImmunityBio Main Business
Table 99. ImmunityBio Latest Developments
Table 100. Nkarta Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 101. Nkarta CAR-NK Cell Therapy Product Offered
Table 102. Nkarta CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Nkarta Main Business
Table 104. Nkarta Latest Developments
Table 105. NKGen Biotech Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 106. NKGen Biotech CAR-NK Cell Therapy Product Offered
Table 107. NKGen Biotech CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. NKGen Biotech Main Business
Table 109. NKGen Biotech Latest Developments
Table 110. ONK Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 111. ONK Therapeutics CAR-NK Cell Therapy Product Offered
Table 112. ONK Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. ONK Therapeutics Main Business
Table 114. ONK Therapeutics Latest Developments
Table 115. Senti Biosciences Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 116. Senti Biosciences CAR-NK Cell Therapy Product Offered
Table 117. Senti Biosciences CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Senti Biosciences Main Business
Table 119. Senti Biosciences Latest Developments
Table 120. Base Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 121. Base Therapeutics CAR-NK Cell Therapy Product Offered
Table 122. Base Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Base Therapeutics Main Business
Table 124. Base Therapeutics Latest Developments
Table 125. Persongen Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 126. Persongen CAR-NK Cell Therapy Product Offered
Table 127. Persongen CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Persongen Main Business
Table 129. Persongen Latest Developments
Table 130. Alpha Biopharma Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 131. Alpha Biopharma CAR-NK Cell Therapy Product Offered
Table 132. Alpha Biopharma CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Alpha Biopharma Main Business
Table 134. Alpha Biopharma Latest Developments
Table 135. Guangzhou Doublle Bioproduct Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 136. Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Product Offered
Table 137. Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Guangzhou Doublle Bioproduct Main Business
Table 139. Guangzhou Doublle Bioproduct Latest Developments
Table 140. Rui Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 141. Rui Therapeutics CAR-NK Cell Therapy Product Offered
Table 142. Rui Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Rui Therapeutics Main Business
Table 144. Rui Therapeutics Latest Developments
Table 145. Allife Medicine Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 146. Allife Medicine CAR-NK Cell Therapy Product Offered
Table 147. Allife Medicine CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Allife Medicine Main Business
Table 149. Allife Medicine Latest Developments
Table 150. Morecell Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 151. Morecell CAR-NK Cell Therapy Product Offered
Table 152. Morecell CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Morecell Main Business
Table 154. Morecell Latest Developments
Table 155. Simnova Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 156. Simnova CAR-NK Cell Therapy Product Offered
Table 157. Simnova CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Simnova Main Business
Table 159. Simnova Latest Developments
Table 160. Nuwacell Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 161. Nuwacell CAR-NK Cell Therapy Product Offered
Table 162. Nuwacell CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Nuwacell Main Business
Table 164. Nuwacell Latest Developments
Table 1. CAR-NK Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-NK Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cytokine Therapy
Table 4. Major Players of Adoptive NK Cell Therapy
Table 5. Major Players of Genetically Engineered NK Cell Therapy
Table 6. Major Players of Others
Table 7. CAR-NK Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 9. Global CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Peripheral Blood (PB)
Table 11. Major Players of Umbilical Cord Blood (CB)
Table 12. Major Players of Induced Pluripotent Stem Cells (iPSCs)
Table 13. Major Players of NK Cell Lines (e.g., NK-92)
Table 14. CAR-NK Cell Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global CAR-NK Cell Therapy Market Size by Cell Source (2021-2026) & ($ millions)
Table 16. Global CAR-NK Cell Therapy Market Size Market Share by Cell Source (2021-2026)
Table 17. Major Players of First Generation
Table 18. Major Players of Second/Third Generation
Table 19. Major Players of Fourth Generation
Table 20. CAR-NK Cell Therapy Market Size CAGR by Product Generation (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global CAR-NK Cell Therapy Market Size by Product Generation (2021-2026) & ($ millions)
Table 22. Global CAR-NK Cell Therapy Market Size Market Share by Product Generation (2021-2026)
Table 23. CAR-NK Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 25. Global CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Table 26. Global CAR-NK Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 27. Global CAR-NK Cell Therapy Revenue Market Share by Player (2021-2026)
Table 28. CAR-NK Cell Therapy Key Players Head office and Products Offered
Table 29. CAR-NK Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global CAR-NK Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 33. Global CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Table 34. Global CAR-NK Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global CAR-NK Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas CAR-NK Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas CAR-NK Cell Therapy Market Size Market Share by Country (2021-2026)
Table 38. Americas CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Table 40. Americas CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Table 42. APAC CAR-NK Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Table 44. APAC CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe CAR-NK Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe CAR-NK Cell Therapy Market Size Market Share by Country (2021-2026)
Table 48. Europe CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa CAR-NK Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa CAR-NK Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa CAR-NK Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of CAR-NK Cell Therapy
Table 54. Key Market Challenges & Risks of CAR-NK Cell Therapy
Table 55. Key Industry Trends of CAR-NK Cell Therapy
Table 56. Global CAR-NK Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global CAR-NK Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global CAR-NK Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global CAR-NK Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. Artiva Biotherapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 61. Artiva Biotherapeutics CAR-NK Cell Therapy Product Offered
Table 62. Artiva Biotherapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Artiva Biotherapeutics Main Business
Table 64. Artiva Biotherapeutics Latest Developments
Table 65. Cartherics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 66. Cartherics CAR-NK Cell Therapy Product Offered
Table 67. Cartherics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Cartherics Main Business
Table 69. Cartherics Latest Developments
Table 70. Cytoimmune Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 71. Cytoimmune Therapeutics CAR-NK Cell Therapy Product Offered
Table 72. Cytoimmune Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Cytoimmune Therapeutics Main Business
Table 74. Cytoimmune Therapeutics Latest Developments
Table 75. Dragonfly Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 76. Dragonfly Therapeutics CAR-NK Cell Therapy Product Offered
Table 77. Dragonfly Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Dragonfly Therapeutics Main Business
Table 79. Dragonfly Therapeutics Latest Developments
Table 80. Fate Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 81. Fate Therapeutics CAR-NK Cell Therapy Product Offered
Table 82. Fate Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Fate Therapeutics Main Business
Table 84. Fate Therapeutics Latest Developments
Table 85. Glycostem Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 86. Glycostem Therapeutics CAR-NK Cell Therapy Product Offered
Table 87. Glycostem Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Glycostem Therapeutics Main Business
Table 89. Glycostem Therapeutics Latest Developments
Table 90. ImmuneBridge Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 91. ImmuneBridge CAR-NK Cell Therapy Product Offered
Table 92. ImmuneBridge CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. ImmuneBridge Main Business
Table 94. ImmuneBridge Latest Developments
Table 95. ImmunityBio Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 96. ImmunityBio CAR-NK Cell Therapy Product Offered
Table 97. ImmunityBio CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. ImmunityBio Main Business
Table 99. ImmunityBio Latest Developments
Table 100. Nkarta Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 101. Nkarta CAR-NK Cell Therapy Product Offered
Table 102. Nkarta CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Nkarta Main Business
Table 104. Nkarta Latest Developments
Table 105. NKGen Biotech Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 106. NKGen Biotech CAR-NK Cell Therapy Product Offered
Table 107. NKGen Biotech CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. NKGen Biotech Main Business
Table 109. NKGen Biotech Latest Developments
Table 110. ONK Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 111. ONK Therapeutics CAR-NK Cell Therapy Product Offered
Table 112. ONK Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. ONK Therapeutics Main Business
Table 114. ONK Therapeutics Latest Developments
Table 115. Senti Biosciences Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 116. Senti Biosciences CAR-NK Cell Therapy Product Offered
Table 117. Senti Biosciences CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Senti Biosciences Main Business
Table 119. Senti Biosciences Latest Developments
Table 120. Base Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 121. Base Therapeutics CAR-NK Cell Therapy Product Offered
Table 122. Base Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Base Therapeutics Main Business
Table 124. Base Therapeutics Latest Developments
Table 125. Persongen Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 126. Persongen CAR-NK Cell Therapy Product Offered
Table 127. Persongen CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Persongen Main Business
Table 129. Persongen Latest Developments
Table 130. Alpha Biopharma Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 131. Alpha Biopharma CAR-NK Cell Therapy Product Offered
Table 132. Alpha Biopharma CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Alpha Biopharma Main Business
Table 134. Alpha Biopharma Latest Developments
Table 135. Guangzhou Doublle Bioproduct Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 136. Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Product Offered
Table 137. Guangzhou Doublle Bioproduct CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Guangzhou Doublle Bioproduct Main Business
Table 139. Guangzhou Doublle Bioproduct Latest Developments
Table 140. Rui Therapeutics Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 141. Rui Therapeutics CAR-NK Cell Therapy Product Offered
Table 142. Rui Therapeutics CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Rui Therapeutics Main Business
Table 144. Rui Therapeutics Latest Developments
Table 145. Allife Medicine Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 146. Allife Medicine CAR-NK Cell Therapy Product Offered
Table 147. Allife Medicine CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Allife Medicine Main Business
Table 149. Allife Medicine Latest Developments
Table 150. Morecell Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 151. Morecell CAR-NK Cell Therapy Product Offered
Table 152. Morecell CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Morecell Main Business
Table 154. Morecell Latest Developments
Table 155. Simnova Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 156. Simnova CAR-NK Cell Therapy Product Offered
Table 157. Simnova CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Simnova Main Business
Table 159. Simnova Latest Developments
Table 160. Nuwacell Details, Company Type, CAR-NK Cell Therapy Area Served and Its Competitors
Table 161. Nuwacell CAR-NK Cell Therapy Product Offered
Table 162. Nuwacell CAR-NK Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Nuwacell Main Business
Table 164. Nuwacell Latest Developments
LIST OF FIGURES
Figure 1. CAR-NK Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-NK Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-NK Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-NK Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. CAR-NK Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-NK Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Global CAR-NK Cell Therapy Market Size Market Share by Cell Source in 2025
Figure 11. Global CAR-NK Cell Therapy Market Size Market Share by Product Generation in 2025
Figure 12. CAR-NK Cell Therapy in Solid Tumors
Figure 13. Global CAR-NK Cell Therapy Market: Solid Tumors (2021-2026) & ($ millions)
Figure 14. CAR-NK Cell Therapy in Hematological Malignancies
Figure 15. Global CAR-NK Cell Therapy Market: Hematological Malignancies (2021-2026) & ($ millions)
Figure 16. Global CAR-NK Cell Therapy Market Size Market Share by Application in 2025
Figure 17. Global CAR-NK Cell Therapy Revenue Market Share by Player in 2025
Figure 18. Global CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 19. Americas CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 20. APAC CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 21. Europe CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 23. Americas CAR-NK Cell Therapy Value Market Share by Country in 2025
Figure 24. United States CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC CAR-NK Cell Therapy Market Size Market Share by Region in 2025
Figure 29. APAC CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 30. APAC CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 31. China CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. India CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe CAR-NK Cell Therapy Market Size Market Share by Country in 2025
Figure 38. Europe CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 39. Europe CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 40. Germany CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. France CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. UK CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 48. Egypt CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 54. APAC CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 55. Europe CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 57. United States CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 58. Canada CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 59. Mexico CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 60. Brazil CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 61. China CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 62. Japan CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. Korea CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. India CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. Australia CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. Germany CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. France CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. UK CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. Italy CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. Russia CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Egypt CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. South Africa CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. Israel CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 75. Turkey CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 76. Global CAR-NK Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global CAR-NK Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 1. CAR-NK Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-NK Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-NK Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-NK Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. CAR-NK Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-NK Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Global CAR-NK Cell Therapy Market Size Market Share by Cell Source in 2025
Figure 11. Global CAR-NK Cell Therapy Market Size Market Share by Product Generation in 2025
Figure 12. CAR-NK Cell Therapy in Solid Tumors
Figure 13. Global CAR-NK Cell Therapy Market: Solid Tumors (2021-2026) & ($ millions)
Figure 14. CAR-NK Cell Therapy in Hematological Malignancies
Figure 15. Global CAR-NK Cell Therapy Market: Hematological Malignancies (2021-2026) & ($ millions)
Figure 16. Global CAR-NK Cell Therapy Market Size Market Share by Application in 2025
Figure 17. Global CAR-NK Cell Therapy Revenue Market Share by Player in 2025
Figure 18. Global CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 19. Americas CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 20. APAC CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 21. Europe CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa CAR-NK Cell Therapy Market Size 2021-2026 ($ millions)
Figure 23. Americas CAR-NK Cell Therapy Value Market Share by Country in 2025
Figure 24. United States CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC CAR-NK Cell Therapy Market Size Market Share by Region in 2025
Figure 29. APAC CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 30. APAC CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 31. China CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. India CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe CAR-NK Cell Therapy Market Size Market Share by Country in 2025
Figure 38. Europe CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 39. Europe CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 40. Germany CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. France CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. UK CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa CAR-NK Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa CAR-NK Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa CAR-NK Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 48. Egypt CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries CAR-NK Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 54. APAC CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 55. Europe CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 57. United States CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 58. Canada CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 59. Mexico CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 60. Brazil CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 61. China CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 62. Japan CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. Korea CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. India CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. Australia CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. Germany CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. France CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. UK CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. Italy CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. Russia CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Egypt CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. South Africa CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. Israel CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 75. Turkey CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
Figure 76. Global CAR-NK Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global CAR-NK Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries CAR-NK Cell Therapy Market Size 2027-2032 ($ millions)
